{"id":1531,"date":"2018-11-23T08:58:59","date_gmt":"2018-11-23T07:58:59","guid":{"rendered":"http:\/\/www.nanexa.com\/?p=1531"},"modified":"2018-11-23T08:58:59","modified_gmt":"2018-11-23T07:58:59","slug":"nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/","title":{"rendered":"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen"},"content":{"rendered":"

Pressmeddelande<\/p>\n

Uppsala 2018-11-23<\/p>\n

\u00a0<\/strong><\/p>\n

Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae<\/sup>-processen<\/strong><\/p>\n

Nanexa har nu f\u00e4rdigst\u00e4llt det s\u00e4kerhetslaboratorrium i Uppsala som m\u00f6jligg\u00f6r f\u00f6r bolaget att arbeta med cytostatika och andra potenta l\u00e4kemedel. Laboratoriet har byggts efter g\u00e4llande arbetsmilj\u00f6best\u00e4mmelser samt \u00e4r anpassat f\u00f6r att kunna tillverka material f\u00f6r anv\u00e4ndning i s\u00e5v\u00e4l prekliniska som kliniska studier. Nanexa har nu kapacitet f\u00f6r att tillverka pr\u00f6vningsmaterial f\u00f6r kliniska studier f\u00f6r bland annat bolagets produktprojekt NEX-18.<\/p>\n

 <\/p>\n

Nanexas VD David Westberg kommenterar:<\/em><\/p>\n

Som vi ser det \u00e4r detta en helt v\u00e4rldsunik enhet. Det \u00e4r h\u00f6gst sannolikt den f\u00f6rsta anl\u00e4ggningen f\u00f6r ALD (Atomic Layer Deposition) \u00e4mnad f\u00f6r att bel\u00e4gga potenta l\u00e4kemedel och dessutom f\u00f6rberedd f\u00f6r att tillverka under GMP-f\u00f6rh\u00e5llanden (Good Manufacturing Practice), vilket \u00e4r en n\u00f6dv\u00e4ndighet f\u00f6r material som skall anv\u00e4ndas till kliniska studier. <\/em><\/p>\n

\u00a0<\/em>Det \u00e4r ocks\u00e5 en betydande styrka att vi har byggt upp den kapaciteten inom Bolaget, vilken g\u00f6r att vi kan arbeta flexibelt med befiintlig personal och utan att vara beroende av andra f\u00f6retags inbokningar och prioriteringar. <\/em><\/p>\n

\u00a0<\/em><\/p>\n

F\u00f6r mer information kontakta:<\/p>\n

David Westberg \u2013 VD, Nanexa AB (publ)<\/p>\n

Telefon: 0709 – 42 83 03<\/p>\n

E-post:\u00a0david.westberg@nanexa.se<\/a><\/p>\n

www.nanexa.com<\/a><\/p>\n

 <\/p>\n

Om Nanexa AB (publ)<\/p>\n

Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell\u00ae<\/sup>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae<\/sup>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pressmeddelande<\/p>\n

Uppsala 2018-11-23<\/p>\n

\u00a0<\/p>\n

Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen<\/p>\n

Nanexa har nu f\u00e4rdigst\u00e4llt det s\u00e4kerhetslaboratorrium i Uppsala som m\u00f6jligg\u00f6r f\u00f6r bolaget att arbeta med cytostatika och andra potenta l\u00e4kemedel.<\/p>\n

L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1531","post","type-post","status-publish","format-standard","hentry","category-pressmeddelanden"],"acf":[],"yoast_head":"\nNanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Pressmeddelande Uppsala 2018-11-23 \u00a0 Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen Nanexa har nu f\u00e4rdigst\u00e4llt det s\u00e4kerhetslaboratorrium i Uppsala som m\u00f6jligg\u00f6r f\u00f6r bolaget att arbeta med cytostatika och andra potenta l\u00e4kemedel.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-23T07:58:59+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen\",\"datePublished\":\"2018-11-23T07:58:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/\"},\"wordCount\":288,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Pressmeddelanden\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/\",\"name\":\"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2018-11-23T07:58:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen - Nanexa AB","og_description":"Pressmeddelande Uppsala 2018-11-23 \u00a0 Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen Nanexa har nu f\u00e4rdigst\u00e4llt det s\u00e4kerhetslaboratorrium i Uppsala som m\u00f6jligg\u00f6r f\u00f6r bolaget att arbeta med cytostatika och andra potenta l\u00e4kemedel.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/","og_site_name":"Nanexa AB","article_published_time":"2018-11-23T07:58:59+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen","datePublished":"2018-11-23T07:58:59+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/"},"wordCount":288,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Pressmeddelanden"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/","url":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/","name":"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2018-11-23T07:58:59+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-har-fardigstallt-sakerhetslaboratorium-for-pharmashell-processen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa har f\u00e4rdigst\u00e4llt s\u00e4kerhetslaboratorium f\u00f6r PharmaShell\u00ae-processen"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1531"}],"version-history":[{"count":1,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1531\/revisions"}],"predecessor-version":[{"id":1532,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1531\/revisions\/1532"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}